Clinical trial
Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers
NCT00062530 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Unknown status
Key facts
| NCT number | NCT00062530 |
|---|---|
| Title | Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers |
| Official title | Development of an Oral Prime-Boost AIDS Vaccine to Elicit Broadly Neutralizing Antibodies Against HIV-1 |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Biological |
| Interventions | SCBaL/M9 |
| Enrollment | 38 |
| First posted | Jun 12, 2003 |
| Last update posted | Sep 26, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: